1359:HKEXChina Cinda Asset Management Co., Ltd. Analysis
Data as of 2026-07-19 - not real-time
HK$0.95
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
China Cinda is trading well below its intrinsic valuation, with the discounted cash‑flow model indicating a price appreciably higher than the current market level. The short‑term moving average sits beneath the medium‑term average, and the longer‑term average is also higher, confirming a bearish technical alignment. Momentum indicators are neutral, while the relative strength index hovers near the midpoint, suggesting limited upside momentum at present. Volume has been on a downtrend, which may constrain short‑term price rebounds, but the stock offers an attractive dividend yield that is supported by a payout ratio comfortably below half of earnings. The balance sheet shows substantial leverage, yet the company generates solid operating cash flow and maintains a low beta, indicating limited systematic risk. Overall, the combination of undervaluation, sustainable dividend, and modest growth potential points to a buying opportunity for patient investors.
Investors should monitor the support zone for signs of price stabilization and watch for any regulatory developments affecting distressed‑asset managers in China, as these could influence risk perception. The high historical drawdown underscores the need for disciplined position sizing, but the current pricing relative to fair value and target estimates suggests meaningful upside if the broader market sentiment improves.
Investors should monitor the support zone for signs of price stabilization and watch for any regulatory developments affecting distressed‑asset managers in China, as these could influence risk perception. The high historical drawdown underscores the need for disciplined position sizing, but the current pricing relative to fair value and target estimates suggests meaningful upside if the broader market sentiment improves.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Technical alignment shows bearish bias
- Decreasing volume limits immediate upside
- Dividend yield provides income cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Price below discounted cash‑flow fair value
- Target price estimates imply significant upside
- Sustainable dividend supports total return
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- High leverage could constrain earnings growth
- Low beta suggests limited market‑wide volatility exposure
- Diversified asset‑management activities provide stability
Key Metrics & Analysis
Financial Health
Revenue Growth14.40%
Profit Margin13.21%
P/E Ratio15.8
ROE0.09%
ROA0.01%
Debt/Equity452.15
P/B Ratio0.2
Op. Cash FlowHK$26.6B
Industry P/E17.8
Technical Analysis
TrendBearish
RSI40.3
SupportHK$0.92
ResistanceHK$1.08
MA 20HK$0.97
MA 50HK$1.04
MA 200HK$1.20
MACDBullish
VolumeDecreasing
Fear & Greed Index87.91
Valuation
Fair ValueHK$0.96
Target PriceHK$1.28
Upside/Downside34.33%
GradeUndervalued
TypeBlend
Dividend Yield3.39%
Risk Assessment
Beta0.41
Volatility29.33%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.